과도한 주간 졸림증 시장 보고서(2026년)

Excessive daytime sleepiness is a health condition marked by a continual difficulty in staying awake and alert during normal waking hours. It is frequently linked to underlying sleep disorders, neurological issues, or lifestyle factors that disturb normal sleep patterns. This condition can substantially affect daily functioning, cognitive abilities, and overall quality of life.

The key treatment types of excessive daytime sleepiness include pharmacological treatment, behavioral therapy, continuous positive airway pressure therapy, lifestyle modification programs, and combination therapies. Pharmacological treatment refers to the use of medications to reduce sleepiness and improve wakefulness in affected patients. These treatments are applied using diagnostic methods such as polysomnography, multiple sleep latency tests, actigraphy, clinical evaluation, and questionnaire-based assessments. The types of disorder include narcolepsy, obstructive sleep apnea, insomnia, circadian rhythm disorders, idiopathic hypersomnia, restless legs syndrome, and other disorders. The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies, and the end users are hospitals, sleep clinics, ambulatory surgical centers, and home care settings.

Tariffs are impacting the excessive daytime sleepiness market by increasing costs of imported CPAP devices, wearable monitoring equipment, diagnostic tools, and pharmaceutical manufacturing inputs. Healthcare providers in North America and Europe are most affected due to reliance on imported medical devices, while Asia-Pacific faces higher costs for exporting sleep therapy equipment. These tariffs are increasing treatment costs and slowing device replacement cycles. However, they are also encouraging domestic medical device manufacturing, regional supply chain development, and innovation in cost-efficient sleep monitoring and therapy solutions.

The excessive daytime sleepiness market research report is one of a series of new reports from The Business Research Company that provides excessive daytime sleepiness market statistics, including excessive daytime sleepiness industry global market size, regional shares, competitors with a excessive daytime sleepiness market share, detailed excessive daytime sleepiness market segments, market trends and opportunities, and any further data you may need to thrive in the excessive daytime sleepiness industry. This excessive daytime sleepiness market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The excessive daytime sleepiness market size has grown strongly in recent years. It will grow from $5.39 billion in 2025 to $5.9 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increasing prevalence of sleep disorders, rising awareness of sleep health impacts, growth in sleep clinic infrastructure, availability of pharmacological wake-promoting agents, expansion of diagnostic sleep testing services.

The excessive daytime sleepiness market size is expected to see strong growth in the next few years. It will grow to $8.52 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing demand for personalized sleep treatment plans, rising integration of digital therapeutics in sleep care, expansion of remote patient monitoring adoption, growing focus on preventive sleep healthcare, increasing investment in sleep medicine research. Major trends in the forecast period include increasing adoption of wearable sleep monitoring devices, growing use of combination therapy approaches, expansion of home-based sleep disorder management, rising focus on early diagnosis and screening programs, enhanced integration of digital sleep health platforms.

The increasing prevalence of obstructive sleep apnea (OSA) is expected to propel the growth of the excessive daytime sleepiness (EDS) market going forward. Obstructive sleep apnea is a sleep disorder marked by repeated breathing interruptions during sleep caused by upper airway obstruction, resulting in disrupted sleep patterns and reduced sleep quality. The incidence of obstructive sleep apnea is rising due to increasing obesity rates, as excess fat around the neck and throat narrows the airway and triggers breathing disturbances during sleep. Excessive daytime sleepiness is a frequent and debilitating symptom associated with obstructive sleep apnea and often persists in a substantial portion of patients, driving demand for targeted treatment and management options. For instance, in August 2026, according to the National Library of Medicine, a US-based medical library, approximately 76.6 million adults aged 30-69 in the United States are projected to be affected by obstructive sleep apnea by 2050. Therefore, the rising prevalence of obstructive sleep apnea is fueling the growth of the excessive daytime sleepiness market.

Leading companies operating in the excessive daytime sleepiness market are focusing on developing innovative solutions, such as central nervous system depressants, to improve wakefulness and enhance quality of life for patients. A central nervous system depressant is a substance that reduces nervous system activity, causing sedation, calmness, or sleep. For example, in September 2025, Amneal Pharmaceuticals Inc., a US-based pharmaceutical company, received approval from the FDA for sodium oxybate oral solution, which directly treats excessive daytime sleepiness (EDS) in narcolepsy patients. It enhances treatment continuity by facilitating virtual specialist consultations, remote prescription fulfillment, and improved patient reach in underserved regions, with the purpose of expanding access, improving affordability, and aligning established pharmacotherapy with evolving digital and telehealth-driven care models for excessive daytime sleepiness.

In October 2025, Alkermes plc, an Ireland-based biopharmaceutical company, acquired Avadel Pharmaceuticals plc for an undisclosed amount. Through this acquisition, Alkermes seeks to accelerate its entry into the sleep medicine market, diversify its product portfolio with the FDA-approved LUMRYZ therapy, and strengthen its capabilities in rare and central disorders of hypersomnolence. Avadel Pharmaceuticals plc is an Ireland-based commercial-stage biopharmaceutical company that provides treatments for excessive daytime sleepiness.

Major companies operating in the excessive daytime sleepiness market are Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Cleveland Clinic, EisAI Co. Ltd, Jazz Pharmaceuticals plc., Emory Healthcare Inc., Alkermes plc., Fisher & Paykel Healthcare Corporation Limited, Harmony Biosciences Holdings Inc., Medanta, Axsome Therapeutics Inc., Compumedics Limited, BIOPROJET, Apnimed Inc., Nox Health Inc., Somnogen Canada Inc., Suven Life Sciences Limited, Theranexus, XWPharma, NLS Pharmaceutics AG.

North America was the largest region in the excessive daytime sleepiness market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the excessive daytime sleepiness market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the excessive daytime sleepiness market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The excessive daytime sleepiness market consists of revenues earned by entities by providing services such as sleep disorder diagnosis and assessment, sleep monitoring and polysomnography services, patient counseling and behavioral therapy sessions, and treatment planning and management. The market value includes the value of related goods sold by the service provider or included within the service offering. The excessive daytime sleepiness market also includes sales of stimulants, modafinil and armodafinil, sodium oxybate, continuous positive airway pressure (CPAP) devices, wearable sleep monitoring devices, and other supportive medical devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Excessive Daytime Sleepiness Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses excessive daytime sleepiness market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for excessive daytime sleepiness ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The excessive daytime sleepiness market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Treatment Type: Pharmacological Treatment; Behavioral Therapy; Continuous Positive Airway Pressure Therapy; Lifestyle Modification Programs; Combination Therapies
• 2) By Diagnosis Method: Polysomnography; Multiple Sleep Latency Test; Actigraphy; Clinical Evaluation; Questionnaire Based Assessments
• 3) By Type Of Disorder: Narcolepsy; Obstructive Sleep Apnea; Insomnia; Circadian Rhythm Disorders; Idiopathic Hypersomnia; Restless Legs Syndrome; Other Type Of Disorders
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End User: Hospitals; Sleep Clinics; Ambulatory Surgical Centers; Home Care Settings
• Subsegments:
• 1) By Pharmacological Treatment: Wake Promoting Medications; Central Nervous System Stimulant Medications; Dopamine Reuptake Inhibitor Medications; Histamine Receptor Modulating Medications
• 2) By Behavioral Therapy: Cognitive Behavioral Therapy For Sleep; Sleep Hygiene Education Programs; Stimulus Control Therapy; Sleep Restriction Therapy
• 3) By Continuous Positive Airway Pressure Therapy: Fixed Pressure Airway Therapy; Auto Adjusting Airway Therapy; Bilevel Airway Therapy; Adaptive Pressure Support Therapy
• 4) By Lifestyle Modification Programs: Sleep Schedule Regulation Programs; Diet And Nutrition Management Programs; Physical Activity And Exercise Programs; Stress Management And Relaxation Programs
• 5) By Combination Therapies: Medication And Behavioral Therapy Combinations; Airway Therapy And Lifestyle Modification Combinations; Medication And Airway Therapy Combinations; Integrated Multimodal Treatment Approaches
• Companies Mentioned: Eli Lilly and Company; Takeda Pharmaceutical Company Limited; Teva Pharmaceutical Industries Ltd.; Cleveland Clinic; EisAI Co. Ltd; Jazz Pharmaceuticals plc.; Emory Healthcare Inc.; Alkermes plc.; Fisher & Paykel Healthcare Corporation Limited; Harmony Biosciences Holdings Inc.; Medanta; Axsome Therapeutics Inc.; Compumedics Limited; BIOPROJET; Apnimed Inc.; Nox Health Inc.; Somnogen Canada Inc.; Suven Life Sciences Limited; Theranexus; XWPharma; NLS Pharmaceutics AG.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Excessive Daytime Sleepiness Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Excessive Daytime Sleepiness Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Excessive Daytime Sleepiness Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Excessive Daytime Sleepiness Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Wearable Sleep Monitoring Devices
  • 4.2.2 Growing Use Of Combination Therapy Approaches
  • 4.2.3 Expansion Of Home-Based Sleep Disorder Management
  • 4.2.4 Rising Focus On Early Diagnosis And Screening Programs
  • 4.2.5 Enhanced Integration Of Digital Sleep Health Platforms

5. Excessive Daytime Sleepiness Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Sleep Clinics
• 5.3 Ambulatory Surgical Centers
• 5.4 Home Care Providers
• 5.5 Diagnostic Laboratories

6. Excessive Daytime Sleepiness Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Excessive Daytime Sleepiness Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Excessive Daytime Sleepiness PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Excessive Daytime Sleepiness Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Excessive Daytime Sleepiness Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Excessive Daytime Sleepiness Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Excessive Daytime Sleepiness Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Excessive Daytime Sleepiness Market Segmentation

• 9.1. Global Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmacological Treatment, Behavioral Therapy, Continuous Positive Airway Pressure Therapy, Lifestyle Modification Programs, Combination Therapies
• 9.2. Global Excessive Daytime Sleepiness Market, Segmentation By Diagnosis Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polysomnography, Multiple Sleep Latency Test, Actigraphy, Clinical Evaluation, Questionnaire Based Assessments
• 9.3. Global Excessive Daytime Sleepiness Market, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Narcolepsy, Obstructive Sleep Apnea, Insomnia, Circadian Rhythm Disorders, Idiopathic Hypersomnia, Restless Legs Syndrome, Other Type Of Disorders
• 9.4. Global Excessive Daytime Sleepiness Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
• 9.5. Global Excessive Daytime Sleepiness Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Sleep Clinics, Ambulatory Surgical Centers, Home Care Settings
• 9.6. Global Excessive Daytime Sleepiness Market, Sub-Segmentation Of Pharmacological Treatment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Wake Promoting Medications, Central Nervous System Stimulant Medications, Dopamine Reuptake Inhibitor Medications, Histamine Receptor Modulating Medications
• 9.7. Global Excessive Daytime Sleepiness Market, Sub-Segmentation Of Behavioral Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cognitive Behavioral Therapy For Sleep, Sleep Hygiene Education Programs, Stimulus Control Therapy, Sleep Restriction Therapy
• 9.8. Global Excessive Daytime Sleepiness Market, Sub-Segmentation Of Continuous Positive Airway Pressure Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Fixed Pressure Airway Therapy, Auto Adjusting Airway Therapy, Bilevel Airway Therapy, Adaptive Pressure Support Therapy
• 9.9. Global Excessive Daytime Sleepiness Market, Sub-Segmentation Of Lifestyle Modification Programs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sleep Schedule Regulation Programs, Diet And Nutrition Management Programs, Physical Activity And Exercise Programs, Stress Management And Relaxation Programs
• 9.10. Global Excessive Daytime Sleepiness Market, Sub-Segmentation Of Combination Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Medication And Behavioral Therapy Combinations, Airway Therapy And Lifestyle Modification Combinations, Medication And Airway Therapy Combinations, Integrated Multimodal Treatment Approaches

10. Excessive Daytime Sleepiness Market Regional And Country Analysis

• 10.1. Global Excessive Daytime Sleepiness Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Excessive Daytime Sleepiness Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Excessive Daytime Sleepiness Market

• 11.1. Asia-Pacific Excessive Daytime Sleepiness Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Excessive Daytime Sleepiness Market

• 12.1. China Excessive Daytime Sleepiness Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Excessive Daytime Sleepiness Market

• 13.1. India Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Excessive Daytime Sleepiness Market

• 14.1. Japan Excessive Daytime Sleepiness Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Excessive Daytime Sleepiness Market

• 15.1. Australia Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Excessive Daytime Sleepiness Market

• 16.1. Indonesia Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Excessive Daytime Sleepiness Market

• 17.1. South Korea Excessive Daytime Sleepiness Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Excessive Daytime Sleepiness Market

• 18.1. Taiwan Excessive Daytime Sleepiness Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Excessive Daytime Sleepiness Market

• 19.1. South East Asia Excessive Daytime Sleepiness Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Excessive Daytime Sleepiness Market

• 20.1. Western Europe Excessive Daytime Sleepiness Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Excessive Daytime Sleepiness Market

• 21.1. UK Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Excessive Daytime Sleepiness Market

• 22.1. Germany Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Excessive Daytime Sleepiness Market

• 23.1. France Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Excessive Daytime Sleepiness Market

• 24.1. Italy Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Excessive Daytime Sleepiness Market

• 25.1. Spain Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Excessive Daytime Sleepiness Market

• 26.1. Eastern Europe Excessive Daytime Sleepiness Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Excessive Daytime Sleepiness Market

• 27.1. Russia Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Excessive Daytime Sleepiness Market

• 28.1. North America Excessive Daytime Sleepiness Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Excessive Daytime Sleepiness Market

• 29.1. USA Excessive Daytime Sleepiness Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Excessive Daytime Sleepiness Market

• 30.1. Canada Excessive Daytime Sleepiness Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Excessive Daytime Sleepiness Market

• 31.1. South America Excessive Daytime Sleepiness Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Excessive Daytime Sleepiness Market

• 32.1. Brazil Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Excessive Daytime Sleepiness Market

• 33.1. Middle East Excessive Daytime Sleepiness Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Excessive Daytime Sleepiness Market

• 34.1. Africa Excessive Daytime Sleepiness Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Excessive Daytime Sleepiness Market, Segmentation By Treatment Type, Segmentation By Diagnosis Method, Segmentation By Type Of Disorder, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Excessive Daytime Sleepiness Market Regulatory and Investment Landscape

36. Excessive Daytime Sleepiness Market Competitive Landscape And Company Profiles

• 36.1. Excessive Daytime Sleepiness Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Excessive Daytime Sleepiness Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Excessive Daytime Sleepiness Market Company Profiles
  • 36.3.1. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Cleveland Clinic Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Eisai Co. Ltd Overview, Products and Services, Strategy and Financial Analysis

37. Excessive Daytime Sleepiness Market Other Major And Innovative Companies

• Jazz Pharmaceuticals plc., Emory Healthcare Inc., Alkermes plc., Fisher & Paykel Healthcare Corporation Limited, Harmony Biosciences Holdings Inc., Medanta, Axsome Therapeutics Inc., Compumedics Limited, BIOPROJET, Apnimed Inc., Nox Health Inc., Somnogen Canada Inc., Suven Life Sciences Limited, Theranexus, XWPharma

38. Global Excessive Daytime Sleepiness Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Excessive Daytime Sleepiness Market

41. Excessive Daytime Sleepiness Market High Potential Countries, Segments and Strategies

• 41.1 Excessive Daytime Sleepiness Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Excessive Daytime Sleepiness Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Excessive Daytime Sleepiness Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer